Page last updated: 2024-12-07

siroheme

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID70678545
CHEBI ID28599
MeSH IDM0053843

Synonyms (4)

Synonym
[3,3',3'',3'''-[(7s,8s,12s,13s)-3,8,13,17-tetrakis(carboxymethyl)-8,13-dimethyl-7,8,12,13-tetrahydroporphyrin-2,7,12,18-tetrayl-kappan(21),kappan(22),kappan(23),kappan(24)]tetrapropanoato(2-)]iron
sirohaem
CHEBI:28599
SIROHEME ,
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Pathways (3)

PathwayProteinsCompounds
Mycobacterium tuberculosis biological processes3962
Sulfur compound metabolism1929
Cysteine synthesis from O-acetylserine715

Research

Studies (76)

TimeframeStudies, This Drug (%)All Drugs %
pre-199020 (26.32)18.7374
1990's24 (31.58)18.2507
2000's14 (18.42)29.6817
2010's12 (15.79)24.3611
2020's6 (7.89)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (5.26%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other72 (94.74%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]